{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:52Z","timestamp":1792460572286,"version":"4.5.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1210\/jc.2016-3628","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T11:11:18Z","timestamp":1492600278000},"page":"1511-1519","source":"Crossref","is-referenced-by-count":58,"title":["Effects of Metreleptin in Pediatric Patients With Lipodystrophy"],"prefix":"10.1210","volume":"102","author":[{"given":"Rebecca J.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adelia","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina I.","family":"Rother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Gorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"issue":"11","key":"key\n\t\t\t\t20170505135320_B1","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: lipodystrophies: genetic and acquired body fat disorders","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20170505135320_B2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4158\/EP09155.RA","article-title":"Rationale for leptin-replacement therapy for severe lipodystrophy","volume":"16","year":"2010","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t20170505135320_B3"},{"issue":"8","key":"key\n\t\t\t\t20170505135320_B4","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/dc13-0561","article-title":"Novel forms of lipodystrophy: why should we care?","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"issue":"10","key":"key\n\t\t\t\t20170505135320_B5","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20170505135320_B6","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"key\n\t\t\t\t20170505135320_B8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","year":"2002","journal-title":"J Med Genet"},{"issue":"3","key":"key\n\t\t\t\t20170505135320_B9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-6143.2004.00358.x","article-title":"Successful renal transplantation in a patient with congenital generalized lipodystrophy: a case report","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2007-1856","article-title":"Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy","volume":"93","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170505135320_B11"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","year":"2010","journal-title":"Diabetologia"},{"issue":"5","key":"key\n\t\t\t\t20170505135320_B13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2013.02.007","article-title":"The liver diseases of lipodystrophy: the long-term effect of leptin treatment","volume":"59","year":"2013","journal-title":"J Hepatol"},{"issue":"7","key":"key\n\t\t\t\t20170505135320_B15","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","article-title":"Long-term efficacy of leptin replacement in patients with generalized lipodystrophy","volume":"54","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/17512433.2016.1096772","article-title":"Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy","volume":"9","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"key\n\t\t\t\t20170505135320_B17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cen.12980","article-title":"Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy","volume":"85","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version","volume":"109","year":"2002","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170505135320_B20"},{"issue":"6","key":"key\n\t\t\t\t20170505135320_B21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Nonalcoholic Steatohepatitis Clinical Research Network","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B22","first-page":"45","article-title":"Lymphoma in acquired generalized lipodystrophy","volume":"57","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"key\n\t\t\t\t20170505135320_B23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20170505135320_B24","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","year":"2002","journal-title":"J Clin Invest"},{"issue":"5-6","key":"key\n\t\t\t\t20170505135320_B25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000341398","article-title":"Consequences of stopping and restarting leptin in an adolescent with lipodystrophy","volume":"78","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"key\n\t\t\t\t20170505135320_B26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.20672","article-title":"Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy","volume":"41","year":"2005","journal-title":"Hepatology"},{"issue":"11","key":"key\n\t\t\t\t20170505135320_B27","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/ajt.12436","article-title":"Post-liver transplant leptin results in resolution of severe recurrence of lipodystrophy-associated nonalcoholic steatohepatitis","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"issue":"7","key":"key\n\t\t\t\t20170505135320_B28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200104150-00012","article-title":"Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation","volume":"71","year":"2001","journal-title":"Transplantation"},{"issue":"1","key":"key\n\t\t\t\t20170505135320_B29","first-page":"35","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1975","volume":"292","year":"1975","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20170505135320_B30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.yhbeh.2013.01.014","article-title":"Metabolic control of puberty: roles of leptin and kisspeptins","volume":"64","year":"2013","journal-title":"Horm Behav"},{"issue":"8","key":"key\n\t\t\t\t20170505135320_B31","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20170505135320_B32","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1210\/jc.2016-1005","article-title":"Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/5\/1511\/16630046\/jc.2016-3628.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T15:03:50Z","timestamp":1503587030000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article-lookup\/doi\/10.1210\/jc.2016-3628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,1,23]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3628","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727460161.793565866","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]}}}